News Hong Kong biotechs IPOs face lower valuations after Ascletis flop Piotr Wnuk Ascletis, Biotech, Hong Kong, pharma in China 0 Comment Biotechs taking an advantage of new Hong Kong exchange rules have been told to expect lower valuations, after Share X Hong Kong biotechs IPOs face lower valuations after Ascletis flop https://pharmaphorum.com/news/hong-kong-biotech-ipos-face-lower-valuations-after-ascletis-flop/
News/ R&D Hepatitis drug wins award for cure rate and efficacy Joy Persaud Ascletis, Ganovo, Hepatitis, hepatitis C 0 Comment Hepatitis C drug Ganovo won a top clinical research award due to its successful performance in a phase Share X Hepatitis drug wins award for cure rate and efficacy https://pharmaphorum.com/news/hepatitis-drug-wins-award/
